[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100617894":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":16,"locations":22,"responsibleParty":43,"collaborators":47,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":55,"acronym":56,"eligibilityCriteria":57,"healthyVolunteers":53,"sex":58,"minAge":59,"maxAge":7,"enrollmentInfo":60,"targetDuration":7,"studyType":63,"phases":7,"briefSummary":64,"conditions":65,"keywords":68,"overallStatus":25,"whyStopped":7,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Ohio State University","OTHER",null,[9,13],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DEVICE","Matched pair Aristotle 14 guidewire and Plato 17 microcatheter","Participants will be randomized in 1:1 ratio to either use of study devices (matched pair Aristotle and Plato) or standard of care (surgeon combination preference) using block randomization method with a fixed block size of 4 ensuring 50% will be randomized to study devices group and 50% randomized to standard of care group.",{"type":10,"name":14,"description":15,"armGroupLabels":7,"otherNames":7},"Surgeon combination preference","Surgeon will decide the on guidewire and microcatheter to use for MMA embolization",[17],{"name":18,"role":19,"phone":20,"phoneExt":7,"email":21},"Edouard Belizaire","CONTACT","614.366.6936","edouard.belizaire@osumc.edu",[23],{"facility":24,"status":25,"city":26,"state":27,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"The Ohio State University Wexner Medical Center","RECRUITING","Columbus","Ohio","43210","United States","US",{"type":32,"coordinates":33},"Point",[34,35],-82.99879,39.96118,{"lat":35,"lon":34},[38,41],{"name":39,"role":19,"phone":40,"phoneExt":7,"email":21},"Edouard J Belizaire, BA","614-366-6936",{"name":7,"role":19,"phone":42,"phoneExt":7,"email":7},"6143666936",{"type":44,"investigatorFullName":45,"investigatorTitle":46,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Patrick Youssef","M.D",[48],{"name":49,"class":50},"Scientia Vascular, Inc.","UNKNOWN","100617894","microfabricated-microcatheter-advantages-in-middle-meningeal-artery-embolization-an-early-experience-at-a-single-center-100617894",false,"NCT07324551","Microfabricated Microcatheter Advantages in Middle Meningeal Artery Embolization: an Early Experience at a Single Center","SCIENTIA","Inclusion Criteria:\n\n* Age ≥ 18 years old\n* Patient or legally authorized representative (LAR) signs an informed consent form\n* Confirmed diagnosis of subacute or chronic subdural hematoma, defined as 50% or more chronic blood\n* Pre-morbid Modified Rankin Score of ≤ 3\n\nExclusion Criteria:\n\n* Age \\\u003C 18 years old\n* Potentially dangerous anatomic variations leading to increased procedural risk or unsafe access for MMA embolization\n* Unmanaged, uncontrolled bleeding disorders\u002Fblood diathesis\n* Presumed septic embolus, or suspicion of microbial superinfection\n* Contraindication to angiography\n* CT or MRI evidence of intra-cranial tumor or mass lesion","ALL","18 Years",{"count":61,"type":62},100,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to evaluate the function of matched pair Aristotle 14 Guidewire and Plato Microcatheter in MMA embolization treatment for chronic subdural hematoma compared to surgeon's preference",[66,67],"Chronic Subdural Hematoma","Hemorrhage Brain",[69,70,66],"MMA Embolization","cSDH","2025-12-23",{"date":73,"type":74},"2026-01-07","ACTUAL",{"date":76,"type":74},"2025-11-03",{"date":78,"type":62},"2029-07-01",{"name":5,"class":6},1]